Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.

Simple Summary: Here, we evaluated whether circulating tumor DNA (ctDNA) measured after neoadjuvant therapy (NAT) or surgery can help to assess tumor response and predict recurrence risk in patients with locally advanced rectal cancer, including those managed non-operatively (NOM). In this large rea...

Full description

Bibliographic Details

Published in:	Cancers Vol. 18; no. 4; pp. 589 - 606
Main Authors:	Chakrabarti, Sakti, Cohen, Stacey A., Tin, Antony, Dangl, Autumn, Chung, Ki Y., Tejani, Mohamedtaki A., Fakih, Marwan G., Chandana, Sreenivasa R., Donahue, Colleen A., George, Virgilio, Malla, Midhun, Aushev, Vasily N., George, Giby V., Ortiz, J. Bryce, Herter, Whitney K., Nagarajan, Arun, Weinberg, Benjamin A., Sharma, Vivek R., Botta, Gregory P., Cho, May
Format:	research tables/charts Journal Article
Published:	MDPI Feb2026
Online Access:	View this record in EBSCOhost